These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14122799)

  • 1. POLYMYXIN B AND COLISTIN. A CRITICAL COMPARISON.
    NORD NM; HOEPRICH PD
    N Engl J Med; 1964 May; 270():1030-5. PubMed ID: 14122799
    [No Abstract]   [Full Text] [Related]  

  • 2. TOXICITY OF COLISTIN AND POLYMYXIN B.
    Holmes KK
    N Engl J Med; 1964 Sep; 271():633-4. PubMed ID: 14172981
    [No Abstract]   [Full Text] [Related]  

  • 3. POLYMYXIN B AND COLISTIN: IN VITRO ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA.
    EICKHOFF TC; FINLAND M
    Am J Med Sci; 1965 Feb; 249():172-4. PubMed ID: 14257308
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL STUDIES ON PSEUDOMONAS AERUGINOSA INFECTIONS. 2. ON THE SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA TO ANTIBIOTICS, WITH SPECIAL REFERENCE TO COLISTIN].
    TAKIGAMI T; TANI S; KITAMOTO O
    Nihon Densenbyo Gakkai Zasshi; 1964 Feb; 37():401-8. PubMed ID: 14126272
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DEVELOPMENT OF RESISTANCE IN BAC. PYOCYANEUS TO CERTAIN ANTIBIOTICS].
    CHERNOMORDIK AB; GAVRISHOVA NA
    Antibiotiki; 1964 Jan; 9():60-2. PubMed ID: 14191805
    [No Abstract]   [Full Text] [Related]  

  • 7. SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS.
    BARNETT M; BUSHBY SR; WILKINSON S
    Br J Pharmacol Chemother; 1964 Dec; 23(3):552-74. PubMed ID: 14256814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA TO ANTIBIOTICS, ESPECIALLY TO COLISTIN.
    TAKIGAMI T; TANI S; KITAMOTO O
    Jpn J Exp Med; 1963 Dec; 33():385-94. PubMed ID: 14148096
    [No Abstract]   [Full Text] [Related]  

  • 10. New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin.
    Vaara M
    Med Res Rev; 2018 Sep; 38(5):1661-1673. PubMed ID: 29485690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [OXYTETRACYCLINE-POLYMYXIN B IN THE TREATMENT OF CHRONIC SUPPURATIVE OTITIS MEDIA WITH ASSOCIATED FUNGI].
    SIERRA J
    Medicina (Madr); 1963 Sep; 31():411-4. PubMed ID: 14092173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhaled colistin in cystic fibrosis].
    Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on administration method of chemotherapeutic agents. 16. Effect of polymyxin B against Pseudomonas aeruginosa (author's transl)].
    Obana Y; Ohtsuki M; Hirai Y; Nishino T
    Jpn J Antibiot; 1980 May; 33(5):636-40. PubMed ID: 6253700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PSEUDOMONAS AERUGINOSA (PYOCYANIC BACILLUS) IN PULMONARY PATHOLOGY].
    FREOUR P; GERMOUTY J; KANE A
    Poumon Coeur; 1965; 21():65-79. PubMed ID: 14272079
    [No Abstract]   [Full Text] [Related]  

  • 16. TOXIC EFFECTS ON COLISTIN METHANE SULPHONATE IN THE NEW-BORN.
    LAWSON JS; HEWSTONE AS
    Med J Aust; 1964 Jun; 1():917-9. PubMed ID: 14172395
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACUTE BACTERIAL ENDOCARDITIS DUE TO PSEUDOMONAS IN A BURNED PATIENT.
    ROBINSON OG; HOOPES JE; CONN JH; ARTZ CP
    Am Surg; 1964 Sep; 30():617-8. PubMed ID: 14209706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.